Home › Funds › MFS Investment Management › MXCT
MFS Investment Management position in MXCT
MAXCYTE INC · Health Care
Latest position (Q2 2024)499.63K sh
Reported value held$1.96M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.56M | $19.06M | New |
| Q4 2021 | 1.82M | $18.55M | Add |
| Q2 2022 | 2.37M | $11.20M | Add |
| Q3 2022 | 2.54M | $16.53M | Add |
| Q4 2022 | 1.97M | $10.75M | Reduce |
| Q1 2023 | 1.97M | $9.74M | Hold |
| Q2 2023 | 1.95M | $8.95M | Reduce |
| Q3 2023 | 1.95M | $6.09M | Hold |
| Q4 2023 | 2.54M | $11.92M | Add |
| Q1 2024 | 2.53M | $10.58M | Hold |
| Q2 2024 | 499.63K | $1.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- Morgan Stanley 3.69M sh · $4.54M · Q2 2026
- BlackRock Inc 3.06M sh · $3.76M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Two Sigma Investments 1.46M sh · $1.80M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Marshall Wace 1.01M sh · $1.25M · Q2 2026
- Citadel Advisors 955.72K sh · $1.18M · Q2 2026
- Point72 Asset Management 299.85K sh · $368.82K · Q2 2026